Robert J. Schneider

Associate Dean for Therapeutics Alliances

Albert B. Sabin Professor of Microbiology and Molecular Pathogenesis, Department of Microbiology

Professor, Department of Radiation Oncology

Keywords
cancer, developmental genetics, genome integrity, microbiology, pharmacology, RNA biology, stem cell biology
Summary

I am an Associate Director of the NYU Cancer Institute, Director of Translational Cancer Research, and Co-director of the Breast Cancer Research Program at NYU School of Medicine. Our research is directed to three major areas: (1) the molecular and genetic understanding of advanced breast cancers and the development of new treatment strategies and therapeutics for advanced breast cancers, focusing particularly on the role of protein synthesis and mTOR kinase regulation; (2) the molecular understanding of gene regulation by ionizing radiation, particularly its ability to regulate protein synthesis and use of this knowledge for development of new cancer treatment strategies; and (3) regulation of the inflammatory response by targeted rapid degradation of inflammatory cytokine mRNAs, and the connection to cancer development and progression.

Phone

212-263-6006

Fax

212-263-8276

Academic office

450 East 29th Street

New York, NY 10016

Lab Website
Is this your profile?
These focus areas and their associated publications are derived from medical subject headings from PubMed.
represents one publication
Loading...

Albert B. Sabin Professor of Microbiology and Molecular Pathogenesis, Department of Microbiology

Professor, Department of Radiation Oncology

Associate Dean for Therapeutics Alliances

Fellowship, SUNY Stony Brook/Princeton University, Virology-Virus-cell Interactions

MTOR INHIBITION PROLONGS REPRODUCTIVE LONGEVITY IN A MURINE MODEL OF PHYSIOLOGIC OVARIAN AGING. [Meeting Abstract]

Goldman, KN; Chenette, D; Larkin, L; Grifo, J; Keefe, DL; Schneider, RJ

Fertility & sterility. 2017 SEP; 108(3):E2-E2

De, La Parra C; Alard, A; Ernlund, A; Schneider, R J

Cancer research. 2017 July; Conference:(American):

Vanpouille-Box, Claire; Alard, Amandine; Aryankalayil, Molykutty J; Sarfraz, Yasmeen; Diamond, Julie M; Schneider, Robert J; Inghirami, Giorgio; Coleman, C Norman; Formenti, Silvia C; Demaria, Sandra

Nature communications. 2017 Jun 09; 8:15618-15618

Protein synthesis regulation by soy isoflavones metabolite equol in metastatic breast cancer cells [Meeting Abstract]

Cruz-Collazo, A M; De, La Parra C; Schneider, R J; Dharmawardhane, S M

FASEB journal. 2017 April; Conference:(Experimental):

Goldman, Kara N; Chenette, Devon; Arju, Rezina; Duncan, Francesca E; Keefe, David L; Grifo, Jamie A; Schneider, Robert J

Proceedings of the National Academy of Sciences of the United States of America (PNAS). 2017 Mar 7; 114(12):3186-3191

Translational control pathways form a molecular hub that regulates tamoxifen resistance in ER plus breast cancer [Meeting Abstract]

Geter, Phillip A; Schneider, Robert J

Cancer research. 2017 MAR; 77:?-?

Silvera, Deborah; Ernlund, Amanda; Arju, Rezina; Connolly, Eileen; Volta, Viviana; Wang, Jinhua; Schneider, Robert J

Molecular & cellular biology. 2017 Feb 15; 37(5):?-?

Dhage, S; Ernlund, A; Wang, J; Axelrod, D; Berman, R; Roses, D; Schneider, R

Cancer research. 2017 FEB; 77:?-?